Extract:
Based on this comprehensive report published by Gravitas Market Insights, the Novel Vaccine Delivery Systems market is said to witness a significant growth during the forecast years between 2021 and 2028. Vaccinations are primarily given to people of all ages to boost their immune systems and provide protection against various infectious diseases throughout their lives. A vaccination is a disease-causing germ-like agent manufactured from weakened or destroyed microorganisms, their toxins, or one of their surface proteins in most cases. The agent causes the body's immune system to detect it as a threat and kill it. Formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredient throughout the body as required in order to safely achieve its therapeutic effect are all included in novel vaccine delivery.
Report Scope in detail:
This latest report edition of Novel Vaccine Delivery Systems market has been added to our huge database of detailed reports and this envisions to shape the future of all the related businesses. Our team of learned research analysts have studied in-depth and curated the report based on several aspects which include the overview of the market, driving forces, growth rate, market trends, market size, opportunities and challenges of the market; along with detailed competitive analysis on the regional as well as global level. The Novel Vaccine Delivery Systems market research report renders a thorough analysis of the market on a global aspect and aims on several market segmentation. This report also provides deeper perception into the latest trends of the market and pinpoints crucial product developments of the industry. Furthermore, the report collects numerous factors that have accredited to the growth of the market in the recent years.
Market Dynamics:
• The increased coverage of immunisation programmes for various illnesses such as polio, smallpox, COVID, and hepatitis, among others, is a major factor driving the global innovative vaccine delivery system market.
• Increased government support for healthcare infrastructure improvements, as well as significant R&D endeavours to develop vaccines with improved therapeutic potential and fewer side effects, all contribute to the market's growth.
• The government's investment in immunisation programmes, as well as the development of innovative vaccines employing diverse novel methodologies, are propelling the industry forward.
• The market's expansion may be hampered by the high cost and unaffordability of safety syringes.
Novel Vaccine Delivery Systems Market Segmentation:
By Delivery Mode
• Intramuscular
• Intradermal
• Others
By Device
• Syringe
• Smart Syringe
• Conventional Syringe
• Needle free injection System
• Spring-based Injector Systems
• Gas Propelled/Air Forced Injector Systems
• Others
Regional Coverage
• North America
o United States
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
• Asia Pacific
o China
o India
o Japan
o Korea
o Australia
o Southeast Asia
o Rest of Asia-Pacific
• South America
o Brazil
o Argentina
o Colombia
o Rest of South America
• Middle East & Africa
o GCC
o South Africa
o Rest of Middle East & Africa
Competitive Analysis:
Eminent market players have been outlined in order to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various top most manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.
Few of the Key Players Covered in Our Report:
• BECTON, DICKINSON, AND COMPANY
• CAPITAL PARTNERS, LLC (KINDEVA DRUG DELIVERY)
• GERRESHEIMER AG
• INOVIO PHARMACEUTICALS, INC. (BIOJECT MEDICAL TECHNOLOGIES)
• GURNET POINT CAPITAL (CORIUM INTERNATIONAL INC.)
• RETRACTABLE TECHNOLOGIES, INC.
• VAXXAS PTY LTD
• TERUMO CORPORATION
• PHARMAJET, INC.
• CARL ZEISS FOUNDATION (SCHOTT AG)
Impact of COVID19:
The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown and this has majorly impacted numerous industries. Our industry experts are working round-the-clock to identify, accumulate and in-time deliver market analysis due to the effect of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic, and predicted alteration on the future outlook of the industry, by taking into the account the economic, political, technological and social parameters.
Section 1: Executive Summary
1.1. Novel Vaccine Delivery Systems Market Industry 360° outline, Year 2016 - 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. End-User/Device Trends
1.5. Regional Trends
Section 2: Market Dynamics - Novel Vaccine Delivery Systems Market Industry Insights
2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter's Analysis
2.6. Worldwide Industry Landscape, Year 2016 - 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment
Section 3: Global Novel Vaccine Delivery Systems Market, By Delivery Mode
3.1. Segmentation Analysis, By Delivery Mode, 2016-2028
3.2. Market Share Segmentation Analysis, By Delivery Mode, 2016-2028
3.3. Intramuscular
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.4. Intradermal
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
3.5. Others
3.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 4: Global Novel Vaccine Delivery Systems Market, By Device
4.1. Segmentation Analysis, By Device, 2016-2028
4.2. Market Share Segmentation Analysis, By Device, 2016-2028
4.3. Syringe
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.3.2. Smart Syringe
4.3.2.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.3.3. Conventional Syringe
4.3.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.4. Needle free injection System
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.4.2. Spring-based Injector Systems
4.4.2.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.4.3. Gas Propelled/Air Forced Injector Systems
4.4.4. Market estimates and forecast with Growth rate analysis, 2016 - 2028
4.5. Others
4.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 5: Global Novel Vaccine Delivery Systems Market, Regional Analysis
5.1. Global Novel Vaccine Delivery Systems Market, Regional Analysis
5.2. North America, Country level Analysis
5.2.1. North America Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Mode, 2016 - 2028
5.2.2. North America Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Device, 2016 - 2028
5.2.3. United States
5.2.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.2.4. Canada
5.2.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.2.5. Mexico
5.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3. Europe Country level Analysis
5.3.1. Europe Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Mode, 2016 - 2028
5.3.2. Europe Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Device, 2016 - 2028
5.3.3. UK
5.3.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.4. Germany
5.3.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.5. France
5.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.6. Italy
5.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.7. Spain
5.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.8. Russia
5.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.3.9. Rest of Europe
5.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4. Asia-Pacific Country level Analysis
5.4.1. Asia-Pacific Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Mode, 2016 - 2028
5.4.2. Asia-Pacific Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Device, 2016 - 2028
5.4.3. China
5.4.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.4. India
5.4.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.5. Japan
5.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.6. Korea
5.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.7. Australia
5.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.8. Southeast Asia
5.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.4.9. Rest of Asia-Pacific
5.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5. South America Country level Analysis
5.5.1. South America Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Mode, 2016 - 2028
5.5.2. South America Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Device, 2016 - 2028
5.5.3. Brazil
5.5.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5.4. Argentina
5.5.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5.5. Colombia
5.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.5.6. Rest of South America
5.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.6. Middle East & Africa Country level Analysis
5.6.1. MEA Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Delivery Mode, 2016 - 2028
5.6.2. MEA Novel Vaccine Delivery Systems Market estimates and forecast with Growth rate analysis, By Device, 2016 - 2028
5.6.3. GCC
5.6.3.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.6.4. South Africa
5.6.4.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
5.6.5. Rest of Middle East & Africa
5.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 - 2028
Section 6: Company Profile - Novel Vaccine Delivery Systems Market
6.1. BECTON, DICKINSON, AND COMPANY
6.1.1. Business Overview
6.1.2. Product & Service Offering
6.1.3. Overall Revenue
6.1.4. Strategic Outlook
6.2. CAPITAL PARTNERS, LLC (KINDEVA DRUG DELIVERY)
6.2.1. Business Overview
6.2.2. Product & Service Offering
6.2.3. Overall Revenue
6.2.4. Strategic Outlook
6.3. GERRESHEIMER AG
6.3.1. Business Overview
6.3.2. Product & Service Offering
6.3.3. Overall Revenue
6.3.4. Strategic Outlook
6.4. INOVIO PHARMACEUTICALS, INC. (BIOJECT MEDICAL TECHNOLOGIES)
6.4.1. Business Overview
6.4.2. Product & Service Offering
6.4.3. Overall Revenue
6.4.4. Strategic Outlook
6.5. GURNET POINT CAPITAL (CORIUM INTERNATIONAL INC.)
6.5.1. Business Overview
6.5.2. Product & Service Offering
6.5.3. Overall Revenue
6.5.4. Strategic Outlook
6.6. RETRACTABLE TECHNOLOGIES, INC.
6.6.1. Business Overview
6.6.2. Product & Service Offering
6.6.3. Overall Revenue
6.6.4. Strategic Outlook
6.7. VAXXAS PTY LTD
6.7.1. Business Overview
6.7.2. Product & Service Offering
6.7.3. Overall Revenue
6.7.4. Strategic Outlook
6.8. TERUMO CORPORATION
6.8.1. Business Overview
6.8.2. Product & Service Offering
6.8.3. Overall Revenue
6.8.4. Strategic Outlook
6.9. PHARMAJET, INC.
6.9.1. Business Overview
6.9.2. Product & Service Offering
6.9.3. Overall Revenue
6.9.4. Strategic Outlook
6.10. CARL ZEISS FOUNDATION (SCHOTT AG)
6.10.1. Business Overview
6.10.2. Product & Service Offering
6.10.3. Overall Revenue
6.10.4. Strategic Outlook
*Market size and forecast will be provided from 2016-2028, and forecast period would be 2021-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after detailed analysis
| Price : US$ 3285 |
Date : Nov 2024 |
| Category : Telecom and IT |
Pages : 178 |
| Price : US$ 3285 |
Date : Nov 2024 |
| Category : Telecom and IT |
Pages : 175 |
| Price : US$ 3285 |
Date : Nov 2024 |
| Category : Telecom and IT |
Pages : 177 |
Request Sample 
Request Discount 
Inquire Before Buy
